Allogene Therapeutics
Company, FunderROR
Founded
Founded
1 Jan 2017
Sources: ror.org
Trials
Phase 1, Recruiting, 66 people, 25 Jul 2025
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Phase 2, Recruiting, 250 people, 15 Jul 2024
Phase 1, Active, not recruiting, 120 people, 6 Jan 2021
Phase 1/2, Active, not recruiting, 160 people, 4 Jun 2020
Phase 1, Completed, 73 people, 18 Sept 2019
Sources: clinicaltrials.gov